GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Total Equity

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Total Equity : $-0.02 Mil (As of Apr. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics Total Equity?

Advanced Proteome Therapeutics's total equity for the quarter that ended in Apr. 2023 was $-0.02 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Advanced Proteome Therapeutics Total Equity Historical Data

The historical data trend for Advanced Proteome Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Total Equity Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.90 -0.91 -1.38 -2.06 -0.85

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.16 -0.85 -0.85 -1.13 -0.02

Advanced Proteome Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Advanced Proteome Therapeutics's Total Equity for the fiscal year that ended in Jul. 2022 is calculated as

Total Equity=Total Assets(Q: Jul. 2022 )-Total Liabilities(Q: Jul. 2022 )
=0.636-1.487
=-0.85

Advanced Proteome Therapeutics's Total Equity for the quarter that ended in Apr. 2023 is calculated as

Total Equity=Total Assets(Q: Apr. 2023 )-Total Liabilities(Q: Apr. 2023 )
=0.063-0.084
=-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Proteome Therapeutics Total Equity Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Traded in Other Exchanges
Address
8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines